Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 16, 2025 07:30 ET | Source: Micron Biomedical; Emory University

Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology

Next-generation rotavirus vaccine delivered via dissolvable microarray technology addresses leading cause of diarrheal deaths in kids 5 years and younger
June 09, 2025 09:40 ET | Source: Micron Biomedical

Micron Biomedical Names Health Education and Empowerment Advocate, Dr. Jayne Morgan, to Board of Advisors

Dr. Jayne Morgan joins Micron Biomedical's Board of Advisors to promote public education on vaccines and therapeutics delivered without needles.
January 16, 2025 07:00 ET | Source: Micron Biomedical

Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines

Micron Biomedical extends Series A to 33+ Million, led by J2 Ventures and GHIC, to accelerate commercialization of needle-free therapeutics and vaccines.
January 14, 2025 13:59 ET | Source: Micron Biomedical

UPDATE - Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles

Micron Biomedical won the BARDA Patch Forward competition for it collaboration with Zipcode Bio to reduce the impact of influenza globally.
January 13, 2025 14:00 ET | Source: Micron Biomedical

Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles

Micron Biomedical won the BARDA Patch Forward competition for it collaboration with Zipcode Bio to reduce the impact of influenza globally.
January 08, 2025 07:00 ET | Source: Micron Biomedical

CEPI and Micron Biomedical Accelerate Needle-Free Vaccines against Disease X with $3.7 Million Grant to Advance Learnings from COVID-19

OSLO, Norway and ATLANTA, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The Coalition for Epidemic Preparedness Innovations (CEPI) is awarding $3.7 million in new funding to Micron Biomedical to advance...
January 07, 2025 07:00 ET | Source: Micron Biomedical

Micron Biomedical Secures $43 Million in Total Grant Support to Improve Coverage of Measles and Rubella Vaccine and Accelerate World’s First Phase 2 Trial of Needle-Free Drug and Vaccine Technology in Infants

Bill & Melinda Gates Foundation grants to accelerate manufacturing of Micron Biomedical’s needle-free technology for measles rubella vaccines